跳至主要内容
临床试验/NCT05026892
NCT05026892Unknown不适用

Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune Diseases

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2021年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,200
试验地点
1
主要终点
risk factors associated with severity

研究概览

简要总结

Factors associated with severe forms of COVID-19 infection in patients with inflammatory rheumatic diseases (IRD) or Autoimmune Diseases (AID) are unknown. This unprecedented situation leads to empirical and potentially erroneous advice and recommendations for care. Identifying factors associated with severity, in the context of this pandemic, which is expected to last many months, and possibly years, is crucial for future patients. The objective of this work is to identify the factors associated with the occurrence of severe forms of COVID-19 infection in patients with IRD or AID, by combining analysis of 2 large databases.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with known chronic inflammatory rheumatism, auto-immune or auto-inflammatory diseases (Rheumatoid arthritis, Spondyloarthritis, Psoriatic arthritis Lupus, Sjögren's syndrome, Inflammatory Myositis, Systemic Vasculitis, Sarcoidosis, Scleroderma, PPR/Horton's, other ...)
  • At least 18 years old
  • SARS-Cov-2 infection (COVID-19) by biological data (serological or positive Cov-2 PCR) or CT scan images or clinical observations consistent with covid-19 between January 2020 and September 2020
  • data available in the APHP health data center (EDS) or in the french RMD Covid19 cohort

排除标准

  • patients opposed to the use of their data

结局指标

主要结局

risk factors associated with severity

时间窗: during covid infection

Between begining to moderate and moderate to severe group: Severe form is defined by be defined by hospitalization in intensive care unit and/or death. Demographic, Comorbidities (and their treatments), underlying IRD and AID and treatments for IRD or AID will be analysed.

次要结局

  • risk factors associated with severe form(during covid infection)
  • risk factors associated with death(during covid infection)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验